Hatteras Venture Partners ^Investors

Hatteras Venture Partners is a North Carolina-based venture capital firm that specializes in financing biomedical companies. With a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine, the firm aims to build transformational human medicine companies that benefit patients and healthcare professionals. Founded in 2000, Hatteras Venture Partners has a team of experienced professionals with a successful track record in enhancing the value of the companies they invest in. With over $120 million under management, the firm has funded various companies in the healthcare sector, including Endogenex™, a preclinical-stage start-up focused on epigenetic editing, and a clinical-stage AAV gene therapy company focused on reversing or preventing blindness.